Shiga toxin-associated hemolytic uremic syndrome: specificities of adult patients and implications for critical care management

HIGHLIGHTS

• who: Benoit Travert et al. from the Centre Référence des Microangiopathies Thrombotiques (CNR-MAT), France have published the article: Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management, in the Journal: Toxins 2021, 13, 306. of /2021/
• what: The authors show that the clinical presentation of STEC-HUS in adults is far from typical and marked by the prevalence of neurological symptoms and a poorer prognosis.

SUMMARY

Historically, HUS was split between so-called "typical" HUS and "atypical" HUS, a terminology meant . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.